Yaron Werber
Stock Analyst at TD Cowen
(2.57)
# 2,182
Out of 5,132 analysts
45
Total ratings
46.88%
Success rate
4.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $17.58 | +19.45% | 3 | Jan 22, 2026 | |
| RAPT RAPT Therapeutics | Downgrades: Hold | n/a | $57.72 | - | 2 | Jan 20, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $12.78 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $20.52 | +265.50% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $43.92 | +16.12% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $821.96 | +39.42% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $80.63 | +22.78% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $1.87 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.37 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $345.95 | -3.45% | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $32.11 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $47.40 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $27.50 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $216.61 | -29.37% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $105.87 | +15.24% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $8.75 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.91 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.14 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.93 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.97 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.07 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $30.03 | +26.54% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $26.45 | - | 1 | Oct 26, 2021 |
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $17.58
Upside: +19.45%
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: n/a
Current: $57.72
Upside: -
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $12.78
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $20.52
Upside: +265.50%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $43.92
Upside: +16.12%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $821.96
Upside: +39.42%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $80.63
Upside: +22.78%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.87
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.37
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $345.95
Upside: -3.45%
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $32.11
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $47.40
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $27.50
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $216.61
Upside: -29.37%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $105.87
Upside: +15.24%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $8.75
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $31.91
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.14
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.93
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $22.97
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.07
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $30.03
Upside: +26.54%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $26.45
Upside: -